Medincell enters into strategic co-development and licensing agreement with AbbVie to develop next-generation long-acting injectable therapies April 16, 2024 April 16, 2024
[Replay] Medincell Presentation at the 23rd Annual Needham Virtual Healthcare Conference April 11, 2024 April 11, 2024
Unitaid Awards Medincell up to $6 million Extension Grant to Fight Malaria April 8, 2024 April 8, 2024
MedinCell to present at the 23rd Annual Needham Virtual Healthcare Conference March 28, 2024 March 28, 2024
Pharmaceutical Industry Veteran Strategist Philippe Guy Becomes Chairman of MedinCell’s Supervisory Board March 13, 2024 March 13, 2024
[Replay] Medincell Presentation at Evercore ISI 2024 Emerging Biotech Conference February 28, 2024 February 28, 2024
Anh Nguyen stepped down from MedinCell Supervisory Board as Member and Chairman Due to Statutory Age Limit February 19, 2024 February 19, 2024
MedinCell to present at the Evercore ISI 2024 Emerging Biotech Conference February 15, 2024 February 15, 2024
MedinCell’s partner Teva provides guidance for UZEDY in 2024 and an update on olanzapine LAI (mdc-TJK) January 31, 2024 January 31, 2024
Teva announces recruitment completion of phase 3 clinical study of mdc-TJK January 9, 2024 January 9, 2024
